-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
The provincial guidance team for COVID-19 prevention and control has come to Shisi Pharmaceutical to supervise the COVID-19 prevention and control efforts.
Category:
Time：2020-02-15
To implement the requirements of the Party and the government on strengthening COVID-19 prevention and control efforts, in the afternoon of February 14, the provincial guidance team for COVID-19 prevention and control—led by a researcher from the Supervision Division of the Hebei Provincial Health Commission—conducted an on-site inspection at Shijiazhuang Sihua Pharmaceutical Co., Ltd. to assess the implementation of preventive measures by enterprises following the resumption of work and production.
To implement the requirements of the Party and the government on strengthening COVID-19 prevention and control efforts, on the afternoon of February 14, the provincial guidance team for COVID-19 prevention and control—led by a researcher from the Supervision Division of the Hebei Provincial Health Commission—conducted an on-site inspection at Shijiazhuang Sihua Pharmaceutical Co., Ltd. to assess the implementation of preventive measures by enterprises following the resumption of work and production. The team provided guidance to help enterprises further enhance their COVID-19 prevention and control efforts. Relevant experts from the Hebei Provincial Center for Disease Control and Prevention, as well as Jin Kerui, member of the Working Committee and researcher of the Management Committee of Shijiazhuang High-tech Zone, accompanied the inspection team.
The guidance team listened to a report by Wu Hengyao, General Manager of Shisi Pharmaceutical, on the implementation of COVID-19 prevention and control measures.
The guidance group pointed out that it is essential to strengthen awareness of the importance and urgency of epidemic prevention and control efforts, further implement preventive measures, and establish a collaborative prevention and control framework involving joint efforts by all sectors and broad public participation. It is crucial to fulfill local responsibilities, conduct comprehensive and rigorous screening, and establish and improve a coordinated prevention and control mechanism. We must enhance material reserves and organizational support, and educate and guide employees to heighten their self-protection awareness and improve their self-protection capabilities. We need to adopt stricter, more thorough, and more effective measures to ensure that epidemic prevention and control work is carried out effectively.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license